Cellectis Bioresearch, a specialist in genome customization and subsidiary of Cellectis has announced the first edition of The Genome Customization Award. The award is intended for academic research teams across the world who are undertaking targeted modification of the genome of a cell line or that of a model organism using one or more meganucleases provided by Cellectis Bioresearch.
“Through this award, Cellectis bioresearch aims at spreading the use of meganucleases for genome customization, throughout the life sciences community,” explained Marc Le Bozec, the company’s CEO. Priority will be given to innovative projects allowing a technological breakthrough, he adds.
The winning academic team will receive 15,000 euro (US$18,000) to partially fund one postdoctoral fellow recruited to work on the project, for one year, with a possible renewal for a second year.
The deadline for submitting applications is October 1, 2010, and full program details are available at http://www.cellectis-bioresearch.com/award/.